Valuation: WEED, Inc.

Market Cap 2.22M 2.02M 1.86M 1.68M 3.17M 210M 3.28M 22.4M 8.88M 112M 8.35M 8.17M 356M P/E 2024
-7.8x
P/E 2025 -4.28x
Enterprise Value 2.71M 2.46M 2.27M 2.05M 3.86M 255M 4M 27.28M 10.82M 136M 10.17M 9.95M 433M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
40.53%
Yield 2024 *
-
Yield 2025 -
1 day-15.25%
1 week+0.67%
Current month+23.97%
1 month-28.23%
3 months-43.50%
6 months-40.36%
Current year-65.31%
1 week 0.01
Extreme 0.012
0.02
1 month 0.01
Extreme 0.0108
0.02
Current year 0.01
Extreme 0.0108
0.05
1 year 0.01
Extreme 0.0108
0.08
3 years 0.01
Extreme 0.0108
0.11
5 years 0.01
Extreme 0.0108
0.49
10 years 0.01
Extreme 0.0108
15.2
Manager TitleAgeSince
Chief Executive Officer 73 30/09/2014
Corporate Secretary 49 30/09/2014
Director TitleAgeSince
Director/Board Member 49 01/01/2005
Director/Board Member 73 01/01/2005
Date Insider Type Main position Quantity % Market Cap. Importance
18/08/26 Sell

Director

-50,000 0.0337%
29/05/26 Sell

Director

-5,008 0.0034%
24/02/26 Sell

Director

240,605 0.1770%
Change 5-day change 1-year change 3-year change Capi.($)
-15.25%+0.67%-64.51%-81.60% 2.22M
-2.69%-0.48%+51.67%+69.09% 66.33B
-0.92%+7.67%+14.26%+90.92% 60.62B
0.00%+0.39%+20.52%+98.45% 55.5B
+0.14%+2.35%+13.08%+109.47% 47.58B
-2.21%-2.47%+18.60%+36.89% 43.69B
-2.30%-10.40%+167.61%+776.79% 37.27B
+2.15%+1.42%+15.17%+56.49% 36.57B
-2.32%-2.24%+75.52%+52.70% 32.22B
+2.62%+5.90%-36.55%+406.95% 26.58B
Average -2.08%+0.11%+27.54%+161.62% 41B
Weighted average by Cap. -0.83%+0.20%+37.23%+162.19%

Financials

2024 2025
Net sales - -
Net income -511K -463K -428K -386K -728K -48.15M -754K -5.14M -2.04M -25.72M -1.92M -1.88M -81.65M -1.37M -1.24M -1.15M -1.04M -1.96M -129M -2.02M -13.82M -5.48M -69.11M -5.15M -5.04M -219M
Net Debt 292K 265K 245K 221K 416K 27.55M 431K 2.94M 1.17M 14.72M 1.1M 1.07M 46.71M 485K 439K 406K 367K 691K 45.73M 716K 4.88M 1.94M 24.43M 1.82M 1.78M 77.53M
Projected Income Statement - Annual - WEED, Inc.
Logo WEED, Inc.
WEED, Inc. is engaged in the business involving the purchase of land and building commercial grade cultivation centers to consult, assist, manage and lease to licensed dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company and its subsidiaries are focused on various business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations and harvest for research, product development, processing and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the medical cannabis and hemp global market space. The Company, through its subsidiary, Sangre AT, LLC, doing business as Sangre AgroTech, is engaged in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry. Its other subsidiaries include WEED Israel Cannabis Ltd, WEED Australia Ltd, and others.
Employees
2
Date Price Change Volume
13/11/26 $0.0150 -15.25% 19,489
12/11/26 $0.0177 0.00% 126,557
11/11/26 $0.0177 +36.15% 55,339
10/11/26 $0.0130 0.00% 506
09/11/26 $0.0130 -12.75% 3,582
  1. Stock Market
  2. Stocks
  3. BUDZ Stock